PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 14 analysts with an average price target of $91.7. This is a potential upside of $29.08 (46.44%) from yesterday's end of day stock price of $62.62.

PTC Therapeutics's activity chart (see below) currently has 431 price targets and 349 ratings on display. The stock rating distribution of PTCT is 63.33% BUY, 33.33% HOLD and 3.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.68% with an average time for these price targets to be met of 339.25 days.

Highest price target for PTCT is $137, Lowest price target is $55, average price target is $91.7.

Most recent stock forecast was given by BARRY JONAS from TRUIST on 15-Oct-2026. First documented stock forecast 21-Jul-2014.

Best performing analysts who are covering PTCT - PTC Therapeutics:

Joon Lee Kristen Kluska Eva Fortea Verdejo Tiago Fauth Robyn Karnauskas Jonathan Lee

Currently out of the existing stock ratings of PTCT, 19 are a BUY (63.33%), 10 are a HOLD (33.33%), 1 are a SELL (3.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-Oct-2026

$62

$2.76 (4.66%)

$65

6 days ago
(15-Oct-2026)

2/3 (66.67%)

$2.76 (4.66%)

839

Hold Since 19-Feb-2026

$75

$15.76 (26.60%)

$85

14 days ago
(07-Oct-2026)

39/43 (90.7%)

$12.44 (19.88%)

137

Buy Since 03-Apr-2022

$137

$77.76 (131.26%)

$130

1 months ago
(21-Sep-2026)

17/25 (68%)

$71.04 (107.70%)

577

Buy Since 22-Feb-2026

$122

$62.76 (105.94%)

$120

2 months 8 days ago
(13-Aug-2026)

1/4 (25%)

$50.3 (70.15%)

114

Buy Since 19-Feb-2026

$109

$49.76 (84.00%)

$106

2 months 9 days ago
(12-Aug-2026)

1/6 (16.67%)

$37.03 (51.45%)

137

Show more analysts

Please expand the browser size to see the chart

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 339 days for the stock forecasts to be reached, with an average price target met ratio of 77.68%.

Which analyst most recently updated their price target on PTCT (PTC Therapeutics)?

Barry Jonas

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Barry Jonas works at TRUIST and has 29 price targets and 17 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with the highest potential upside of $77.76

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Simos Simeonidis with the lowest potential downside of -$49.24
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?